British medicine producer GSK on Monday noted that it is going to purchase US biopharmaceutical firm IDRx for up to USD1.15 billion. The Boston-originated biotechnology company is producing ...

GSK Plc’s Chief Executive Officer Emma Walmsley is looking to do more deals as the British drugmaker doubles down on its ...

The new facility at Stainton, near Barnard Castle, will power the nearby Glaxo Smith Kline factory for 40 years. The pharmaceutical and biotechnology company said the solar farm will help maintain the ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...

London: GSK plc has announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

“In the end," Vrabel said. "It was clear to me, and to my family, and my soul, that this was the place that I wanted to be.” ...

Major pharmaceutical companies like GSK, Eli Lilly, and Johnson & Johnson are engaging in multi-billion dollar acquisitions ...

We recently published a list of the Top 10 Small Cap Stocks to Buy with the Highest Upside Potential. In this article, we are ...

Moderna ( MRNA) cut its 2025 forecast by $1 billion Monday, citing weak demand for its newest vaccine as well as slow sales for its COVID-19 vaccine.